Solventum Past Earnings Performance
Past criteria checks 2/6
Solventum has been growing earnings at an average annual rate of 2%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been growing at an average rate of 1.5% per year. Solventum's return on equity is 33.5%, and it has net margins of 15.7%.
Key information
2.0%
Earnings growth rate
0.3%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 1.5% |
Return on equity | 33.5% |
Net Margin | 15.7% |
Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How Solventum makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 8,202 | 1,290 | 2,266 | 758 |
31 Dec 23 | 8,197 | 1,346 | 2,247 | 758 |
30 Sep 23 | 8,166 | 1,381 | 2,184 | 754 |
30 Jun 23 | 8,101 | 1,256 | 2,201 | 757 |
31 Mar 23 | 8,083 | 1,286 | 2,238 | 763 |
31 Dec 22 | 8,130 | 1,343 | 2,238 | 767 |
31 Dec 21 | 8,171 | 1,460 | 2,282 | 766 |
31 Dec 20 | 7,281 | 1,138 | 2,169 | 719 |
Quality Earnings: SOLV has high quality earnings.
Growing Profit Margin: SOLV's current net profit margins (15.7%) are lower than last year (15.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SOLV's earnings have grown by 2% per year over the past 5 years.
Accelerating Growth: SOLV's earnings growth over the past year (0.4%) is below its 5-year average (2% per year).
Earnings vs Industry: SOLV earnings growth over the past year (0.4%) did not outperform the Medical Equipment industry 2.6%.
Return on Equity
High ROE: Whilst SOLV's Return on Equity (33.5%) is high, this metric is skewed due to their high level of debt.